Zosia Miedzybrodzka

Medicine & Life Sciences

1. Huntington Disease 100%
2. Mutation 70%
3. Breast Neoplasms 55%
4. Clubfoot 48%
5. Scotland 29%
6. Alleles 29%
7. Ovarian Neoplasms 27%
8. Genes 21%
9. Hyperlipoproteinemia Type II 15%
10. Population 15%
11. Genetic Testing 14%
12. Haplotypes 14%
13. Single Nucleotide Polymorphism 12%
14. Neoplasms 11%
15. Penetrance 10%
16. Research Personnel 10%
17. Cost-Benefit Analysis 9%
18. Delivery of Health Care 9%
19. Pedigree 8%
20. Genetic Counseling 8%
21. Germ-Line Mutation 8%
22. Genetic Services 8%
23. Methylenetetrahydrofolate Reductase (NADPH2) 8%
24. Genome 8%
25. Lim Kinases 7%
26. Child 7%
27. Health 7%
28. Guidelines 7%
29. Genome-Wide Association Study 7%
30. Genotype 6%
31. Age of Onset 6%
32. Autistic Disorder 6%
33. Rare Diseases 6%
34. Phenotype 6%
35. Neurodevelopmental Disorders 6%
36. Confidence Intervals 6%
37. Gefitinib 6%
38. Parents 6%
39. BRCA1 Gene 6%
40. ErbB Receptors 6%
41. DNA Repair 6%
42. Costs and Cost Analysis 6%
43. Atypical Rett Syndrome 5%
44. Giant Axonal Neuropathy 5%
45. Idiopathic basal ganglia calcification 1 5%
46. Counseling 5%
47. Mothers 5%
48. Gene Frequency 5%
49. North Sea 5%
50. Social Work 5%